Table 5.
Author year | Data source, territory, population | N | Age | Outcomes |
Choi 2020 [51] | Retrospective chart reviews between January 2012 and March 2017 in a tertiary hospital Korea | 11 | Children | Median age months (IQR): |
Type 1 SMA | •Patients began tube feeding: 6 (3–7) | |||
•Discontinuation of oral breaks/milk feeding: 6 (3–6.5) | ||||
The main reasons for switching to tube feeding were poor oral intake, recurrent pneumonia, and aspiration | ||||
Kaneko 2017 [14] | Japanese individuals enrolled by questionnaire who completed the questionnaire | 112 | Adults and children | Median age at the start of tube feeding support (range), months: |
Types 1–3 SMA | •Type 1 : 47 | •Type 1a SMA (n = 36): 4 (1–40) | ||
•Type 2 : 42 | •Type 1b SMA (n = 2): 12.5 (12–13) | |||
•Type 3 : 23 | ||||
Wadman 2021 [13] | Data from a single-center retrospective study in the UK and a prospective multicenter study in Italy | 146 | Children and adolescents | Median age at starting of feeding difficulties (range), years: |
Type 2 SMA | •Total cohort (n = 146): 6.5 (0–16.5) | |||
•UK (n = 72): 6.9 (0–17) | ||||
•Italy (n = 74): 6.0 (2–10) | ||||
Median age at starting nasogastric tube (range), years: | ||||
•UK (n = 72): 4.1 (1–17) | ||||
•Italy (n = 74): NA | ||||
Median age at gastrostomy (range), years: | ||||
•UK (n = 72): 7.3 (3–19) | ||||
•Italy (n = 74): NA |
Abbreviations: IQR = interquartile range; NA = not applicable; SMA = spinal muscular atrophy.